<DOC>
	<DOCNO>NCT00171262</DOCNO>
	<brief_summary>To analyze efficacy fluvastatin patient chronic renal disease analyze certain inflammatory marker . In addition , tolerability safety also evaluate Spanish population .</brief_summary>
	<brief_title>Trial Evaluate Efficacy Fluvastatin Certain Markers</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>Patients &gt; 18 year Patients give inform consent Pregnant woman Diabetic patient Treated statin year prior study inclusion Patients contraindication list fluvastatin prescribing information Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Dyslipidemia , chronic renal disease , fluvastatin</keyword>
</DOC>